Showing results (491-500 of 981) with videos related to

Sort By:
Pageof 99
Cardiovascular Therapeutics|July 20, 2016
Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunctionSavitree Thummasorn, Nattayaporn Apaijai, Sasiwan Kerdphoo, et al.
Cardiovascular Therapeutics|July 31, 2016
Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirinKathleen A Packard, Daniel E Hilleman
Cardiovascular Therapeutics|April 24, 2015
Downregulation of miR-21 is involved in direct actions of ursolic acid on the heart: implications for cardiac fibrosis and hypertrophyXingli Dong, Shangkun Liu, Lingling Zhang, et al.
Cardiovascular Therapeutics|August 11, 2016
Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)Kyung-Jin Kim, Sang-Hyun Kim, Young Won Yoon, et al.
Cardiovascular Therapeutics|May 8, 2023
Cardioprotection of mAb2G4/ODN/lip on Myocardial Ischemia-Reperfusion Injury via Inhibiting the NF-κB Signaling PathwayZujin Xu, Zhuoran Wei, Yali Zhu, et al.
Cardiovascular Therapeutics|July 7, 2015
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated HypercholesterolemiaRobert Krysiak, Wojciech Gilowski, Witold Szkrobka, et al.
Cardiovascular Therapeutics|July 16, 2015
Effects of the Galanin Receptor Antagonist M40 on Cardiac Function and Remodeling in Rats with Heart FailureAo Chen, Min Li, Lei Song, et al.
Cardiovascular Therapeutics|October 28, 2017
The effects of single- and multiple-dose administration of bococizumab (RN316/PF-04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studiesBarry Gumbiner, Tenshang Joh, Hong Liang, et al.
Cardiovascular Therapeutics|February 22, 2018
Vascular dysfunction elicited by a cross talk between periaortic adipose tissue and the vascular wall is reversed by pioglitazoneIsabel Quesada, Jimena Cejas, Rodrigo García, et al.
Cardiovascular Therapeutics|December 2, 2017
Hemodynamic impact of pulmonary vasodilators on single ventricle physiologyBiagio Castaldi, Giulia Bordin, Massimo Padalino, et al.
Pageof 99